Search results
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 1 day agoTreating America’s obesity epidemic is turning into big business. Two pharmaceutical companies, Eli...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 13 hours agoThe second quarter could also meet that benchmark, with earnings expected to grow 32% to $2.78 per...
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
CNBC· 2 days agoAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, Dec. 11,...
Novo Nordisk, Eli Lilly drop on Amgen competition concerns By Investing.com
Investing.com· 7 days agoShares of Novo Nordisk (NYSE:NVO) and Eli Lilly & Co. (NYSE:LLY) are down premarket Friday as competition in the GLP-1 market. Amgen (NASDAQ:AMGN) disclosed that it looked ...
Lilly (LLY) Reliance on International Sales: What Investors Need to Know
Zacks via Yahoo Finance· 4 days agoDid you analyze how Eli Lilly (LLY) fared in its international operations for the quarter ending...
3 Stocks to Buy Following Guidance Upgrades
Zacks via Yahoo Finance· 11 hours agoGuidance lifts are among the most positive announcements shareholders can hear, injecting confidence in the long-term picture. And that's precisely what...
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 3 days agoThe injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24,...
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 4 days agoEli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Benzinga via Yahoo Finance· 2 days agoThe open public hearing portion of the meeting will be conducted virtually. The Phase 3 study...
Lilly Declares Second-Quarter 2024 Dividend
FOX21 Colorado Springs· 4 days agoThe board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock. The dividend ...
